TFEB Antibodies

Santa Cruz Biotechnology delivers a wide array of TFEB Antibodies for investigating transcription factor EB (TFEB) in cellular processes. TFEB Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TFEB is a key regulator of lysosomal biogenesis and autophagy, playing a crucial role in cellular homeostasis and metabolism. Research has shown that TFEB activity significantly impacts neurodegenerative diseases and cancer through its influence on lysosomal function. Understanding TFEB regulation and function can reveal new therapeutic approaches for various pathological conditions. Investigating TFEB expression patterns helps scientists uncover its role in cellular stress responses and metabolic adaptation. TFEB research continues to expand our knowledge of cellular quality control mechanisms and tissue homeostasis. Studying TFEB's interaction with other transcription factors provides valuable insights into gene regulation networks. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TFEB's role in health and disease.